1. Synthesis and In Vivo Imaging of N-(3-[11C]Methoxybenzyl)-2-(3-Methoxyphenyl)ethylaniline as a Potential Targeting Agent for P-glycoprotein
- Author
-
Marco Macchia, Silvia Pardini, Luca Menichetti, Annalina Lapucci, Giulia Nesi, Piero Salvadori, Antonietta Bartoli, Sabrina Fucci, Debora Petroni, Silvia Burchielli, Simona Rapposelli, and Maria Digiacomo
- Subjects
0301 basic medicine ,Cancer Research ,Tariquidar ,Multidrug resistance ,P-glycoprotein ,Pharmacology ,01 natural sciences ,Arylethylphenoxy derivatives ,Arylethylphenylamine derivatives ,CNS radiotracers ,Pgp inhibitor ,[11C]-Methylation ,Oncology ,Radiology, Nuclear Medicine and Imaging ,03 medical and health sciences ,In vivo ,Nuclear Medicine and Imaging ,medicine ,Radiology, Nuclear Medicine and imaging ,biology ,medicine.diagnostic_test ,Chemistry ,Transporter ,0104 chemical sciences ,Multiple drug resistance ,010404 medicinal & biomolecular chemistry ,030104 developmental biology ,Positron emission tomography ,biology.protein ,Efflux ,Radiology ,Preclinical imaging ,medicine.drug - Abstract
Purpose The plasma membrane P-glycoprotein (Pgp) is an efflux transporter involved in multidrug resistance and in the onset of neurodegenerative disease. Its function and most mechanisms of action are still under investigation. We developed a C-11-labeled 2-arylethylphenylamine-([11C]AEPH) derivative for positron emission tomography (PET), as a novel probe to better understand the activity and the function of Pgp in vivo.
- Published
- 2016